WDIV-TV Detroit features Henry Ford patient’s treatment with Modus V™

Henry Ford Medical Center using Modus V™ and BrightMatter™ Plan and Guide

Surgical and treatment advances made possible by Synaptive’s Modus V™ and BrightMatter™ technology were featured in a WDIV-TV Detroit story that profiled a local woman’s brain surgery at Henry Ford Medical Center.

The news report details how patient Christy Lhamon has battled brain cancer since 2006. Initially given a grim diagnosis, Lhamon suffered from repeat episodes of progression with her disease that Henry Ford neurosurgeon Dr. Ian Lee says left her with limited treatment options.

Through the use of BrightMatter and Modus V, the latter of which Henry Ford recently acquired, Dr. Lee was able to remove more of Lhamon’s brain tumor than previously possible.

A tumor sample removed during the surgery also underwent genetic testing, leading to the surprise discovery that her tumor had a mutation more common in kidney cancers. This insight opened new treatment options for Lhamon that would not have otherwise been considered. Lhamon says she is hopeful her latest surgery and new treatment course will let her resume a normal life.

“BrightMatter technology allowed us to visualize the white matter tracts—kind of the highways of information in the brain—to visualize where the motor fibers are. It’s important to know where these fibers are to know where the danger zones are so that you can stay away from them during surgery,” Dr. Lee told WDIV-TV.

Read the full story here.